Literature DB >> 17361032

Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease.

Z Khalil1, D LoGiudice, B Khodr, P Maruff, C Masters.   

Abstract

BACKGROUND: The concept that the neurotoxicity of amyloid beta protein could partly result from vascular effects that may be detected in peripheral microcirculation is new.
METHODS: We compared peripheral endothelial vascular responses of patients with early clinically confirmed Alzheimer's disease (AD) to that of people with normal cognition and those with other forms of dementia. Acetylcholine (ACh) was iontophoresed into the skin and the resultant vasodilator response was measured using laser Doppler flowmetery.
RESULTS: The ratio of ACh response to saline (ratio E/S) was determined. Mean +/- SEM of ratios E/S were 8.8 +/- 0.9 for controls (n=168), 1.4 +/- 0.1 for AD patients (n=80) and 3.1 +/- 0.5 for other dementia (n=84). Using the optimal cut-off point of E/S ratio of 1.9, an 80% diagnostic sensitivity and specificity for AD have been observed. When the control sample was filtered for those with cardiovascular diseases and with MMSE < 28, this improved the specificity to 90% (n=119). Furthermore, 15 subjects were randomly drawn from a longitudinal healthy ageing study. Five of those subjects met the criteria for mild cognitive impairment (MCI) after eight years of follow up using a battery of cognitive tests. When tested for their E/S ratio in a blind fashion, the skin test successfully identified those subjects.
CONCLUSIONS: The results support our hypothesis that endothelial alterations can be detected early in the course of the disease. We suggest that this simple skin test could potentially be applied as diagnostic adjunct in patients with mild cognitive symptoms or those with early clinical evidence of AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361032     DOI: 10.3233/jad-2007-11106

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

1.  Potential biomarkers for vascular damage in Alzheimer's disease: thrombomodulin and von Willebrand factor.

Authors:  B B Yavuz; D S Dede; B Yavuz; M Cankurtaran; M Halil; Z Ulger; E S Cankurtaran; K Aytemir; G Kabakci; I C Haznedaroglu; S Ariogul
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

2.  Evaluation of a transparent cranial implant as a permanent window for cerebral blood flow imaging.

Authors:  Nami Davoodzadeh; Mildred S Cano-Velázquez; David L Halaney; Carrie R Jonak; Devin K Binder; Guillermo Aguilar
Journal:  Biomed Opt Express       Date:  2018-09-17       Impact factor: 3.732

Review 3.  Current and future uses of neuroimaging for cognitively impaired patients.

Authors:  Gary W Small; Susan Y Bookheimer; Paul M Thompson; Greg M Cole; S-C Huang; Vladimir Kepe; Jorge R Barrio
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

Review 4.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

5.  Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis.

Authors:  Audra L Clos; Rakez Kayed; Cristian A Lasagna-Reeves
Journal:  Front Neurol       Date:  2012-01-20       Impact factor: 4.003

6.  Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension.

Authors:  Selçuk Sen; Nermin Gürel; Baran Ufuktepe; Zeynep Günes Özünal; Çagla Büyüklü; Yagiz Üresin
Journal:  EXCLI J       Date:  2017-03-10       Impact factor: 4.068

7.  Retooling Laser Speckle Contrast Analysis Algorithm to Enhance Non-Invasive High Resolution Laser Speckle Functional Imaging of Cutaneous Microcirculation.

Authors:  Surya C Gnyawali; Kevin Blum; Durba Pal; Subhadip Ghatak; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

8.  Impact of Nitric Oxide Bioavailability on the Progressive Cerebral and Peripheral Circulatory Impairments During Aging and Alzheimer's Disease.

Authors:  Massimo Venturelli; Anna Pedrinolla; Ilaria Boscolo Galazzo; Cristina Fonte; Nicola Smania; Stefano Tamburin; Ettore Muti; Lucia Crispoltoni; Annamaria Stabile; Alessandra Pistilli; Mario Rende; Francesca B Pizzini; Federico Schena
Journal:  Front Physiol       Date:  2018-03-14       Impact factor: 4.566

9.  The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Authors:  Ihab Hajjar; Meaghan Hart; William Milberg; Vera Novak; Lewis Lipsitz
Journal:  BMC Geriatr       Date:  2009-11-18       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.